Reactive hemophagocytic syndrome in adult-onset still disease: Clinical features and long-term outcome: A case-control study of 8 patients

Medicine

Volumn 89, Issue 1, 2010, Pages 37-46

  Hot, Arnaud ^a,b,c   Toh, Myew Ling ^b   Coppéré, Brigitte ^a   Perard, Laurent ^a   Girard Madoux, Marie Hélène ^a   Mausservey, Christelle ^a,c   Desmurs Clavel, Hélène ^a   Ffrench, Martine ^d   Ninet, Jacques ^a,c  

^a Service de Medecine Interne   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; FERRITIN; HAPTOGLOBIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STEROID;

ADULT; ADULT ONSET STILL DISEASE; AGED; ARTHRALGIA; ARTICLE; BLOOD CLOTTING DISORDER; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG MEGADOSE; FEMALE; FERRITIN BLOOD LEVEL; FEVER; GLYCOSYLATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERTRIGLYCERIDEMIA; INTENSIVE CARE UNIT; LABORATORY TEST; LONG TERM CARE; LOW DRUG DOSE; LYMPHADENOPATHY; MALE; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; RASH; REACTIVE HEMOPHAGOCYTIC SYNDROME; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SHOCK; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; STILL'S DISEASE, ADULT-ONSET; TIME FACTORS;

EID: 74549137348     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181caf100     Document Type: Article

References (60)

1. Ahmadi-Simab K, Lamprecht P, Jankowiak C, Gross WL. Successful treatment of refractory adult onset Still's disease with rituximab. Ann Rheum Dis. 2006;65:1117-1118.
2. Amenomori M, Migita K, Miyashita T, Yoshida S, Ito M, Eguchi K, Ezaki H. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still's disease. Clin Exp Rheumatol. 2005;23:100-102.
3. Arlet JB, Le TH, Marinho A, Amoura Z, Wechsler B, Papo T, Piette JC. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis. 2006;65:1596-1601.
4. Bywaters EG. Pathologic aspects of juvenile chronic polyarthritis. Arthritis Rheum. 1977;20(2 Suppl):271-276.
5. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, Dupond JL, Larroche C, Piette AM, Mechenstock D, Ziza JM, Arlaud J, Labussiere AS, Desvaux A, Baty V, Blanche P, Schaeffer A, Piette JC, Guillevin L, Boissonnas A, Christoforov B. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003;49:633-639.
6. Efthimiou P, Georgy S. Pathogenesis and management of adult-onset Still's disease. Semin Arthritis Rheum. 2006;36:144-152.
7. Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottagnoud P, Spaeth PJ, Neftel KA. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol. 2001;68:4-10.
8. Emmenegger U, Reimers A, Frey U, Fux C, Bihl F, Semela D, Cottagnoud P, Cerny A, Spaeth PJ, Neftel KA. Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly. 2002;132:230-236.
9. Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly. 2005;135:299-314.
10. Fardet L, Coppo P, Kettaneh A, Dehoux M, Cabane J, Lambotte O. Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome. Arthritis Rheum. 2008;58:1521-1527.
11. Fautrel B. Ferritin levels in adult Still's disease: any sugar? Joint Bone Spine. 2002;69:355-357. (Pubitemid 34823825)
12. Fautrel B, Sibilia J, Mariette X, Combe B. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis. 2005;64:262-266.
13. Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, Rozenberg S, Piette JC, Bourgeois P. Proposal for a new set of classification criteria for adult-onset Still disease. Medicine (Baltimore). 2002;81:194-200.
14. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000;6:601-608.
15. Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum. 2005;52:1794-1803.
16. Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, Atsumi T, Koike T. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008;47:1686-1691.
17. Gabilondo A, Ojeda E, Aranegi K, Goikoetxea U. [Hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus in an adult with Still disease]. Med Clin (Barc). 2006;127:358-359.
18. Gianella S, Schaer DJ, Schwarz U, Kurrer M, Heppner FL, Fehr J, Seebach JD. Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still's disease and concurrent macrophage activation syndrome. Am JHematol. 2008;83:424-427.
19. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. JPediatr. 1985;106:561-566.
20. Hamidou M, Boutoille D, Masseau A, Garand R, Raffi F [Adult-onset Still disease with hemophagocytic syndrome treated with cyclosporine]. Presse Med. 2005;34:1634-1636.
21. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-131.
22. Hiura Y, Kawabata H, Kanekura T, Terasaki K, Kanzaki T. Hemophagocytic syndrome induced by diaminodiphenylsulfone. J Dermatol. 2007;34:730-731.
23. Iglesias J, Sathiraju S, Marik PE. Severe systemic inflammatory response syndrome with shock and ARDS resulting from Still's disease: clinical response with high-dose pulse methylprednisolone therapy. Chest. 1999;115:1738-1740.
24. Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol. 1997;66:135-151.
25. Imashuku S, Kuriyama K, Sakai R, Nakao Y, Masuda S, Yasuda N, Kawano F, Yakushijin K, Miyagawa A, Nakao T, Teramura T, Tabata Y, Morimoto A, Hibi S. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol. 2003;41:103-109.
26. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection-and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998;12:435-444.
27. Javier RM, Sibilia J, Offner C, Albert A, Kuntz JL. [Macrophage activation syndrome in lupus]. Rev Rhum Ed Fr. 1993;60:831-835.
28. Kadar J, Petrovicz E. Adult-onset Still's disease. Best Pract Res Clin Rheumatol. 2004;18:663-676.
29. Kaito K, Kobayashi M, Katayama T, Otsubo H, Ogasawara Y Sekita T, Saeki A, Sakamoto M, Nishiwaki K, Masuoka H, Shimada T, Yoshida M, Hosoya T. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol. 1997;59:247-253.
30. Kulke R, Koeppel M, Hey D. Treatment of adult Still's disease with intravenous immunoglobulin. Lancet. 1996;347:337.
31. Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol. 2004;14:205-215.
32. Kumakura S, Ishikura H, Munemasa S, Adachi T, Murakawa Y, Kobayashi S. Adult onset Still's disease associated hemophagocytosis. J Rheumatol. 1997;24:1645-1648.
33. Kumari R, Uppal SS. Prolonged remission in adult-onset Still's disease with etanercept. Clin Rheumatol. 2006;25:106-108.
34. Lambotte O, Cacoub P, Costedoat N, Le Moel G, Amoura Z, Piette JC. High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. J Rheumatol. 2003;30:1027-1028.
35. Larroche C, Bruneel F, Andre MH, Bader-Meunier B, Baruchel A, Tribout B, Genereau T, Zunic P. [Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP]. Ann Med Interne (Paris). 2000;151:533-539.
36. Lequerre T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, Kone-Paut I, Michel M, Dernis E, Khellaf M, Limal N, Job-Deslandre C, Fautrel B, Le Loet X, Sibilia J. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis. 2008;67:302-308.
37. Liozon E, Ly K, Aubard Y, Vidal E. Intravenous immunoglobulins for adult Still's disease and pregnancy. Rheumatology (Oxford). 1999;38:1024-1025.
38. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr. 1996;129:750-754.
39. Nishida T, Suzuki K, Kuwada N, Nakamura Y, Motoyoshi K, Kamakura K. Hemophagocytic syndrome and adult Still's disease associated with meningoencephalitis and unconsciousness. Intern Med. 2001;40:1037-1040.
40. Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin. Clin Infect Dis. 2003;36:306-312.
41. Pamuk ON, Pamuk GE, Usta U, Cakir N. Hemophagocytic syndrome in one patient with adult-onset Still's disease. Presentation with febrile neutropenia. Clin Rheumatol. 2006;26:797-800.
42. Papo T, Andre MH, Amoura Z, Lortholary O, Tribout B, Guillevin L, Piette JC. The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus. J Rheumatol. 1999;26: 927-930.
43. Park JH, Bae JH, Choi YS, Lee HS, Jun JB, Jung S, Yoo DH, Bae SC, Kim TH. Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A. J Korean Med Sci. 2004;19:137-141.
44. Pricop L, Galatiuc C, Manciulea M, DeLeo A, Sulica A, Herberman RB, Whiteside TL. Expression of Fc mu receptors on human natural killer cells. Clin Immunol Immunopathol. 1991;59:355-367.
45. Prieur AM, Stephan JL. [Macrophage activation syndrome in rheumatic diseases in children]. Rev Rhum Ed Fr. 1994;61:447-451.
46. Ramanan AV, Baildam EM. Macrophage activation syndrome is hemophagocytic lymphohistiocytosis-need for the right terminology. J Rheumatol. 2002;29:1105 [author reply: 1105].
47. Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr. 1996;128:275-278.
48. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, Viola S, Martini A. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr. 2005;146:598-604.
49. Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore). 1988;67:369-388.
50. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85:421-426.
51. Schifter T, Lewinski UH. Adult onset Still's disease associated with Epstein-Barr virus infection in a 66-year-old woman. Scand J Rheumatol. 1998;27:458-460.
52. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992;13:136-142.
53. Sibilia J, Javier RM, Albert A, Cazenave JP, Kuntz JL. Pancytopenia secondary to hemophagocytic syndrome in rheumatoid arthritis treated with methotrexate and sulfasalazine. J Rheumatol. 1998;25:1218-1220.
54. Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford). 2001;40:1285-1292.
55. Stern A, Riley R, Buckley L. Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy. J Clin Rheumatol. 2001;7:252-256.
56. Suzuki J, Nawata M, Koike M, Wada R, Sekigawa I, Iida N, Hashimoto H. Two cases of reactive hemophagocytic syndrome: a patient with adult onset Still's disease and a patient with herpes zoster and autoimmune abnormalities. Mod Rheumatol. 2001;11:336-339.
57. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327-1330.
58. Tsuda H. Hemophagocytic syndrome (HPS) in children and adults. Int J Hematol. 1997;65:215-226.
59. Vignes S, Wechsler B, Amoura Z, Papo T, Frances C, Huong DL, Veyssier P, Godeau P, Piette JC. Intravenous immunoglobulin in adult. Still's disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol. 1998;16:295-298.
60. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992;19:424-430.